Market revenue in 2023 | USD 182.9 million |
Market revenue in 2030 | USD 278.1 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Stimulants |
Fastest growing segment | Non-stimulants |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stimulants, Non-stimulants |
Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.86% in 2023. Horizon Databook has segmented the India attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
The India attention deficit hyperactivity disorder market is expected to grow at a lucrative rate over the forecast period. The increasing prevalence of diseases and available treatment medicine in generic form at low cost are among the major factors responsible for market growth.
According to the Indian Journal of Psychiatric Nursing, the prevalence of ADHD among adolescents and children ranges from 1.30% to 28.9% of the total population. Thus, the Indian government has undertaken various initiatives to support people living with ADHD by providing training to handle situations.
The government-initiated ONTRAC project, in collaboration with AIIMS Hospital, New Delhi, aims to develop a novel computerized intervention to help increase concentration capacities and lower distractibility in children with ADHD. It is a digital intervention-based, low-cost treatment for children with ADHD.
Horizon Databook provides a detailed overview of country-level data and insights on the India attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into India attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account